OrIGINaLNI radOVI OrIGINaL arTICLEs Immunoexpression of Cathepsin D in primary and recidivant meningiomas

Zorana Vukasinovic-Bokun ,
Zorana Vukasinovic-Bokun
Iva Berisavac ,
Iva Berisavac
Radomir Benovic ,
Radomir Benovic
Milica Lavrnic
Milica Lavrnic

Published: 01.12.2011.

Biochemistry

Volume 28, Issue 1 (2012)

pp. 397-404;

https://doi.org/10.5937/matmed1201397v

Abstract

The present study was performed to establish the socioepidemiological caracteristics (mean age, male to female ratio), the prevalence of various histological types of meningiomas in the groups of primary and recidivant tumors as well as Cathepsin D immunoexpression. We analysed 50 patients with primary and recidivant intracranial and intraspinal meningiomas who underwent surgery in KBC Zemun during the year 2004, with a two years follow-up. All surgical specimen were evaluated for histologic type of tumor and representative slides were immunostained with the anti-Cathepsin D antibody. In both primary and recidivant meningioma groups the number of mitosis, as factor tumor agressivness, was counted on 10 and 20 HPF and those results were statistically analyzed. A considerable difference was found when the number of mitosis and the histologic tumor grade have been compared with the Cathepsin D immunoexpression. The result lead to conlusion that the immunopositivity of Cathepsin D decreases with higher mitosis count and higher tumor grade.

Keywords

References

1.
Perry M, Reifenberger G. Histological classification and molecular genetics of meningiomas. Lancet Neurol. 2006;1045–1045.
2.
Bj M. Villano jL. Update on meningiomas. Oncologist. 2001;(11):1604–13.
3.
David N Louis H, Ohgaki O, Wiestler W, Cavenee. WHO classification of tumors of the central nervous system. 2007;
4.
Manivel J, Jm S. Pathology of meningiomas. Clinicopathologi study of potentially aggressive variant of meningiomas. aM j surg Pathol. 1995;493–505.
5.
Expression of extracellular matrix degrading proteins in classic,atypical and anaplastic meningiomas. Pathology-research and practice. 2006;365–72.
6.
Glondu M, Coopman P, Laurent-Matha V, Garcia M, H. Liaudet Coopman E. a mutated Cathepsin d devoid of its atalytic activity stimulates the growth of cancer cells. Oncogene. 2001;6920–9.
7.
Glondu M, Liaudet-Coopman E, Platet N, Garcia H, M. down-regulation of cathepsin d expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer ells. Oncogene. 2002;5127–34.
8.
Berchem G, Glondu M, Gleizes M, Brouillet Jp, Vignon F, Garcia M, et al. Cathepsin d affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene. 2001;5951–5.
9.
Louis, Bw, Budka H. Meningiomas: Pathology and genetics of tumors of the nervous system. 2000;176–84.
10.
Redecker B, Heckendorf B, Grosch H. Molecular organization of the human Cathepsin d gene. dNa Cell Biol. 1991;423–341.
11.
Rochefort H, Garcia M, Glondu M. Cathepsin d in breast cancer: mehanism and linical applications: a 1999 overwiew. Clin Chim acta. 2000;157–70.
12.
Frohlich E, Morhle B, M. activity expression and transcription rate of Cathepsins B, d, H and L in cutaneous malignant melanoma. Cancer. 2001;972–82.
13.
Nissen a. expression of adhesion factors and degrading proteins in primary and secondary glioblastoma and their precursor tumors. Invasion Metastasis. 1998;27–284.
14.
Patholres Pract. 2000;710–1.
15.
Sivaparvathi M, Chintala Sk. Expression of cathepsin d during the progression of human gliomas. Neurosci Lett. 1996;171–4.
16.
Warich M, Bossanyi V, P. Expression of cathepsin d in human astrocytic neoplasia. Gen diagnPathol. 1995;93–6.
17.
Robson Dk I, Dw R, Wa. Immunolocalization of cathepsin d in the human nervous system and central nervous system neoplasm. Neuropathil appl Neuro-biol. 1990;39–44.
18.
Gottschalk J, Goebel G. Influence of preoperative dexamethason therapy on proliferating cell nuclear antigen (PCNa) expression in comparison to other parameters in meningiomas. Histol Histopathol. 1992;653–61.
19.
Koehorst, Med, Van Der Kallen, Cjh. Progesterone receptor synthesis in human meningiomas: relation to the estrogen-induced proteins ps2 and cathepsin d and influence of epidermal growth factor, forskolin and phorbol ester in vitro. Int j Biol Markers. 1998;16–23.
20.
Cavailles V, Garcia P, M. Estrogenes and growth factors induce the mrNa of the 52 K-procathepsin d secreted by breast cancer cells. Nucleic acid res. 1998;1903–19.
21.
Ma B, Verheijen F, Jacobs J. Occurrence, regulation and significance of progesterone reeptors in human meningioma. steroids. 2000;795–800.
22.
Castilla Ae, Prayson Ra C, Mc, Cohen L. Immunohistochemical expression od Cathepsin d in Meningiomas. am j Clin Pathol. 2003;123–8.

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Partners